Emtricitabine for Naive Chinese Chronic Hepatitis B Patients
Clinical trial NCT02327663 · UNKNOWN
Trial details
- NCT number
- NCT02327663
- Sponsor
- Asian-Pacific Alliance of Liver Disease, Beijing
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2017-06-01
- Enrollment
- 2000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.